Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
2.86
0.03 (1.06%)
At close: Jun 16, 2025, 3:59 PM
2.92
2.09%
Pre-market: Jun 17, 2025, 04:44 AM EDT
Spero Therapeutics Revenue
Spero Therapeutics reported an annual revenue of $27.4M, reflecting a -71.68% growth. For the quarter ending March 31, 2025, Spero Therapeutics generated $5.87M in revenue.
Revenue (ttm)
$27.4M
Revenue Growth
-71.68%
Price / Sales Ratio
2.03
Revenue / Employee
$856.13K
Employees
32
Market Cap
159.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|